# In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)

> **NCT03932240** · PHASE3 · COMPLETED · sponsor: **Emory University** · enrollment: 36 (actual)

## Conditions studied

- Hemostasis

## Interventions

- **DRUG:** Fibrinogen Concentrate (FC)
- **DRUG:** Cryoprecipitate

## Key facts

- **NCT ID:** NCT03932240
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-13
- **Primary completion:** 2021-04-09
- **Final completion:** 2021-11-16
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932240, "In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03932240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*